Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future

被引：0
|
作者：
Plesnila-Frank, C. [1 ]
Rottenkolber, D. [2 ]
Berger, K. [2 ]
机构：
[1] Med Econ Res Grp, Munich, Germany
[2] Univ Hosp Munich, Munich, Germany
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65041-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A283 / A284
页数：2
相关论文
共 50 条
  • [41] Clinical Experience of Decitabine in Elderly Patients with Myelodysplastic Syndromes (MDS)
    Geils, George F., Jr.
    BLOOD, 2009, 114 (22) : 1092 - 1092
  • [42] THE IMPACT OF MYELODYSPLASTIC SYNDROMES (MDS) ON THE MENTAL HEALTH OF PATIENTS AND CAREGIVERS
    Scheurmeyer, Isabel
    Hughes, Mary
    Sloan, Erika
    LeBlanc, Thomas
    Houk, Alice
    Sirewu, Nyaradzo
    ONCOLOGY NURSING FORUM, 2024, 51 (02)
  • [43] Improvement in cytopenias of patients with myelodysplastic syndromes (MDS) in response to thalidomide
    Raza, A
    Lisak, L
    Little, L
    Andrews, C
    Meyer, P
    Ekbal, M
    Venugopal, P
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 103 - 104
  • [44] Combination of thalidomide and Enbrel for the treatment of patients with myelodysplastic syndromes (MDS).
    Raza, A
    Dutt, D
    Lisak, L
    Dean, L
    Fantroy, L
    Gezer, S
    Syed, E
    Goldberg, C
    Loew, J
    Hsu, WT
    Venugopal, P
    BLOOD, 2001, 98 (11) : 273B - 274B
  • [45] CLASSIFICATION AND TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS)
    CATOVSKY, D
    MYELODYSPLASTIC SYNDROMES : PATHOPHYSIOLOGY AND TREATMENT, 1988, 783 : 3 - 3
  • [46] Iron overload in myelodysplastic syndromes (MDS)
    Norbert Gattermann
    International Journal of Hematology, 2018, 107 : 55 - 63
  • [47] PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES (MDS)
    TRICOT, G
    VLIETINCK, R
    HENDRICKX, B
    VERWILGHEN, RL
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (02) : 362 - 362
  • [48] IMMUNOTHERAPY STRATEGIES IN MYELODYSPLASTIC SYNDROMES (MDS)
    Gill, Saar
    LEUKEMIA RESEARCH, 2021, 108 : S57 - S57
  • [49] BMT in children with myelodysplastic syndromes (MDS).
    Kardos, G
    Vossen, JMJJ
    Hoogerbrugge, PM
    BLOOD, 1997, 90 (10) : 373 - 373
  • [50] Cyclosporin A in the treatment of myelodysplastic syndromes (MDS)
    Shirin, AD
    Volkova, MA
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 416 - 416
12345